1,2-dioctanoylglycerol and stemphone

1,2-dioctanoylglycerol has been researched along with stemphone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Miyatake, M; Momose, K; Nobe, H; Nobe, K; Sakai, Y; Takashima, J	1

Other Studies

1 other study(ies) available for 1,2-dioctanoylglycerol and stemphone

Article	Year
Novel diacylglycerol kinase inhibitor selectively suppressed an U46619-induced enhancement of mouse portal vein contraction under high glucose conditions. British journal of pharmacology, 2004, Volume: 143, Issue:1 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta, Thoracic; Benzoquinones; Diacylglycerol Kinase; Diglycerides; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glucose; In Vitro Techniques; Isometric Contraction; Male; Mice; Muscle Contraction; Muscle, Smooth, Vascular; Portal Vein; Subcellular Fractions; Type C Phospholipases; Vasoconstrictor Agents	2004

Article

Year

Novel diacylglycerol kinase inhibitor selectively suppressed an U46619-induced enhancement of mouse portal vein contraction under high glucose conditions.

British journal of pharmacology, 2004, Volume: 143, Issue:1

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta, Thoracic; Benzoquinones; Diacylglycerol Kinase; Diglycerides; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glucose; In Vitro Techniques; Isometric Contraction; Male; Mice; Muscle Contraction; Muscle, Smooth, Vascular; Portal Vein; Subcellular Fractions; Type C Phospholipases; Vasoconstrictor Agents

2004